logo
Plus   Neg
Share
Email

Myriad Genetics Inc. Q1 adjusted earnings of $0.43 per share

Below are the earnings highlights for Myriad Genetics Inc. (MYGN):

-Earnings: -$0.7 million in Q1 vs. $78.8 million in the same period last year.
-EPS: -$0.01 in Q1 vs. $1.12 in the same period last year.
-Excluding items, Myriad Genetics Inc. reported adjusted earnings of $32.8 million or $0.43 per share for the period.
-Revenue: $202.3 million in Q1 vs. $178.8 million in the same period last year.

-Guidance:
Next quarter EPS guidance: $0.36-$0.38
Next quarter revenue guidance: $216 - $218 Mln
Full year EPS guidance: $1.70-$1.75
Full year revenue guidance: $855 - $865 Mln

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT
>